Inferior turbinate hypertrophy
Conditions
Interventions
None listed
Sponsors
Dos Medical B.V.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects must have a diagnosis of bilateral ITH for > 6 weeks 2. Patients are capable of undergoing the coblation procedure under local anesthesia 3. Age = 18 and = 70 years. 4. Subjects must be willing to give Informed Consent and adhere to visit schedules.
Exclusion criteria
Exclusion criteria: 1. Subjects currently treated with anticoagulation other than thrombocyte aggregation inhibitors. 2. The presence of nasal polyps. 3. Known systemic vasculitic and granulomatous disease. 4. Known coagulopathy. 5. Known peanut allergy. 6. AIDS or known to be HIV positive. 7. History of radiotherapy in head and neck region. 8. History of previous turbinate surgery 9. Severe anatomic abnormalities leading to an inability to administer the irrigation solution to one side of the nose (for example a severe septal deviation or a large bullous middle turbinate). 10. Craniofacial malformations. 11. Abnormalities requiring other modality of therapy (obstructive polyps, tumors, infection of dental origin). 12. Subject has a psychiatric, addictive, or any disorder that compromises ability to give truly Informed Consent for participation in this study. 13. Subject may have difficulty in interpreting the questionnaires due to language or cognitive problems. 14. Patient is currently enrolled in other investigational drug trial(s) or is receiving other investigational agent(s).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •Difference in mean overall nasal VAS symptom score between the two arms after 6 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Comparison of nasal patency by means of NL-NOSE scale (questionnaire) • Comparison of nasal endoscopic findings (NES score) • Comparison of PNIF-score before and after treatment. • Comparison of the burden of epistaxis (5-point scale). • Comparison of the burden of nasal discharge (5-point scale). • Difference in VAS symptom score for crust formation. • Difference in VAS symptom score for nasal pain. • Difference in VAS symptom score for loss of smell. | — |
Contacts
Public ContactTjerk Aukema
Rijksuniversiteit Groningen
Outcome results
None listed